SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-017934
Filing Date
2020-04-22
Accepted
2020-04-22 16:30:33
Documents
6
Period of Report
2020-06-04
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A avro-def14a_20200604.htm DEF 14A 1053551
2 GRAPHIC gfsuqnoys5dv000003.jpg GRAPHIC 4003
3 GRAPHIC gfsuqnoys5dv000002.jpg GRAPHIC 2979
4 GRAPHIC gfsuqnoys5dv000001.jpg GRAPHIC 4003
5 GRAPHIC gfsuqnoys5dv000004.jpg GRAPHIC 54530
6 GRAPHIC gfsuqnoys5dv000005.jpg GRAPHIC 35434
  Complete submission text file 0001564590-20-017934.txt   1194520
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38537 | Film No.: 20808223
SIC: 2836 Biological Products, (No Diagnostic Substances)